| Primary |
| Parenteral Nutrition |
48.0% |
| Drug Use For Unknown Indication |
12.0% |
| Lysinuric Protein Intolerance |
10.0% |
| Medication Dilution |
8.0% |
| Chemotherapy |
6.0% |
| Colorectal Cancer |
4.0% |
| Diabetes Mellitus |
4.0% |
| Product Used For Unknown Indication |
4.0% |
| Hypoglycaemia |
2.0% |
| Respiratory Therapy |
2.0% |
|
| Urticaria |
33.3% |
| Anaphylactoid Reaction |
8.3% |
| Chest Pain |
8.3% |
| Flushing |
8.3% |
| Premature Rupture Of Membranes |
8.3% |
| Product Label Issue |
8.3% |
| Underdose |
8.3% |
| Vertebral Artery Thrombosis |
8.3% |
| Vomiting |
8.3% |
|
| Secondary |
| Parenteral Nutrition |
19.4% |
| Product Used For Unknown Indication |
10.5% |
| Drug Use For Unknown Indication |
10.4% |
| Electrolyte Substitution Therapy |
8.5% |
| Pain |
5.1% |
| Thrombosis Prophylaxis |
4.4% |
| Hypertension |
4.0% |
| Drug Therapy |
3.9% |
| Stupor |
3.9% |
| Arthritis |
3.8% |
| Supplementation Therapy |
3.0% |
| Nutritional Support |
2.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.9% |
| Restlessness |
2.8% |
| Sleep Disorder |
2.7% |
| Polyuria |
2.5% |
| Cardiac Failure |
2.4% |
| Diabetes Mellitus |
2.4% |
| Essential Hypertension |
2.3% |
| Fluid Replacement |
2.2% |
|
| Urticaria |
26.2% |
| Toxic Epidermal Necrolysis |
14.0% |
| Stevens-johnson Syndrome |
8.4% |
| Swollen Tongue |
7.5% |
| Thermal Burn |
4.7% |
| Vomiting |
4.7% |
| Convulsion |
3.7% |
| Disseminated Intravascular Coagulation |
3.7% |
| Hyponatraemia |
3.7% |
| Lactic Acidosis |
3.7% |
| Paralysis |
2.8% |
| Pyrexia |
2.8% |
| Anaphylactic Reaction |
1.9% |
| Anaphylactoid Reaction |
1.9% |
| Hypokalaemia |
1.9% |
| Pneumothorax |
1.9% |
| Rales |
1.9% |
| Wheezing |
1.9% |
| White Blood Cell Count Increased |
1.9% |
| Acidosis Hyperchloraemic |
0.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.4% |
| Drug Use For Unknown Indication |
18.7% |
| Prophylaxis |
11.4% |
| Hypertension |
4.8% |
| Fluid Replacement |
4.7% |
| Sedation |
3.6% |
| Infection |
3.6% |
| Nutritional Support |
3.2% |
| Pain |
2.8% |
| Premedication |
2.7% |
| Pneumonia |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Non-small Cell Lung Cancer |
2.4% |
| Supplementation Therapy |
2.3% |
| Diabetes Mellitus |
2.1% |
| Hepatic Neoplasm Malignant |
2.1% |
| Nausea |
2.0% |
| Pyrexia |
1.8% |
| Pneumonia Aspiration |
1.8% |
| Insomnia |
1.8% |
|
| Interstitial Lung Disease |
15.4% |
| Vomiting |
11.8% |
| Renal Failure Acute |
8.2% |
| Sepsis |
6.9% |
| Respiratory Failure |
6.7% |
| Renal Failure |
5.4% |
| Upper Gastrointestinal Haemorrhage |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Pneumonia |
3.6% |
| Pyrexia |
3.6% |
| Stevens-johnson Syndrome |
3.6% |
| Toxic Epidermal Necrolysis |
3.6% |
| Peripheral Sensory Neuropathy |
3.3% |
| Encephalitis Viral |
3.1% |
| Haemoptysis |
3.1% |
| Somnolence |
3.1% |
| Thrombocytopenia |
3.1% |
| Urine Output Decreased |
3.1% |
| Thrombosis |
2.6% |
| Hypoglycaemia |
2.3% |
|
